000 01577 a2200457 4500
005 20250514235251.0
264 0 _c20050907
008 200509s 0 0 eng d
022 _a0003-9926
024 7 _a10.1001/archinte.165.15.1762
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcClung, Michael R
245 0 0 _aOpposite bone remodeling effects of teriparatide and alendronate in increasing bone mass.
_h[electronic resource]
260 _bArchives of internal medicine
_c
300 _a1762-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAlendronate
_xpharmacology
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aBone Remodeling
_xdrug effects
650 0 4 _aCollagen
_xurine
650 0 4 _aCollagen Type I
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aPeptide Fragments
_xblood
650 0 4 _aPeptides
_xurine
650 0 4 _aProcollagen
_xblood
650 0 4 _aTeriparatide
_xpharmacology
700 1 _aSan Martin, Javier
700 1 _aMiller, Paul D
700 1 _aCivitelli, Roberto
700 1 _aBandeira, Francisco
700 1 _aOmizo, Molly
700 1 _aDonley, David W
700 1 _aDalsky, Gail P
700 1 _aEriksen, Erik F
773 0 _tArchives of internal medicine
_gvol. 165
_gno. 15
_gp. 1762-8
856 4 0 _uhttps://doi.org/10.1001/archinte.165.15.1762
_zAvailable from publisher's website
999 _c15726050
_d15726050